Compare Duolingo Inc (DUOL) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duolingo Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Duolingo Inc trades at $149.92 (market cap $7.08B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.5× Duolingo Inc's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Duolingo Inc for 137 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| DUOL | ROIV | |
|---|---|---|
Market Cap | $7.08B | $24.72B |
Volume | 729,171 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $341.08 | $41.81 |
52-Week Low | $90.03 | $16.04 |
Typical Hold Time | 137 Days | 1 Days |
Enterprise Value | $5.85B | $20.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duolingo (DUOL) trades at $151.22, down 0.33% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with 2025 revenue reaching $1.04 billion and net income of $414.07 million, representing a 35.87% net margin. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.66 surpassing the $0.604 estimate. Technical analysis shows support at $150 and resistance at $152, with the stock trading near recent highs.
Duolingo presents a compelling growth story with strong profitability metrics and consistent earnings beats, though valuation multiples remain elevated. Key risks include insider selling activity and competitive pressures in the edtech space. Analyst consensus leans cautious with 54% hold ratings, but the company's AI-driven content creation and user growth strategy provides long-term upside potential if monetization improves.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duolingo Inc
Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
